Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1991): Abbott M+, Lancet 2, 633
Bullous dermatitis
(1994): Gupta AK+, JAmAcadDermatol30, 911
Erythema multiforme
(1994): Gupta AK+, JAmAcadDermatol30, 911
(1991): Gussenhoven MJE+, Lancet 338, 120
Exanthems (>1%)
(2001): Altman EM, West Orange, NJ (from Internet)
(observation)
(1990): Grant SM+, Drugs 39, 877 (1.8%) (in AIDS patients)
Exfoliative dermatitis
(1994): Gupta AK+, JAmAcadDermatol30, 911 (passim)
(1990): Grant SM+, Drugs 39, 877
Fixed eruption
(2006): Mahendra A+, Indian J Dermatol Venereol Leprol
72(5), 391 (oral)
(2004): Goel A+, JDermatol31(4), 345
(2003): Lane JE+, Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 95(2), 129
(2002): Ghislain P-D, JAmAcadDermatol46, 47 (recurrence)
(2001): Hudson TF, Conway, AR (from Internet) (observation)
(2000): Heikkilä H+, JAmAcadDermatol42, 883
(1997): Danby B, Kingston, Ontario (from Internet)
(observation)
(1997): Jaffe P, Columbia, SC (from Internet) (observation)
(1994): Morgan JM+, BMJ 308, 454
Hypertrophy
(1998): Drake L+, JAmAcadDermatol38, S87
Pallor (